Parameter estimates of linear mixed effects models for juvenile <i>M</i>. <i>mercenaria</i>, juvenile <i>M</i>. <i>arenaria</i> and juvenile <i>A</i>. <i>islandica</i> mean shell c... by Teagan McMahon (20108036)

The levels of NF-κB related inflammatory factors, TERT expression and telomerase relative length are significantly increased in the ovarian tissue of PCOS rats. by Haoxuan Xue (19949764)

Certainty of affect predicted by valence and low, medium, and, high trait emotional clarity Predicted certainty of knowing how you feel in a trial, as predicted by the subject’s st... by Anthony G. Vaccaro (5964368)

Baseline Characteristics of Study Participants Stratified by Sleep Duration Categories. by Zhi Jin (3742471)

Subjects:

Incidence of New-Onset Cardiovascular Disease in 2018 Follow-up by Sleep Duration Groups. by Zhi Jin (3742471)

Subjects:

Subgroup Analysis of Sleep Duration and Cardiovascular Disease Risk in Type 2 Diabetes Patients. by Zhi Jin (3742471)

Subjects:

Association of Sleep Duration with Cardiovascular Disease Risk in Type 2 Diabetes Patients: Analysis Using Different Models. by Zhi Jin (3742471)

Subjects:

Flow Chart of Study Participant Selection. by Zhi Jin (3742471)

Subjects:

Linear relationship between sleep duration and cardiovascular disease (CVD) risk in type 2 diabetes patients. by Zhi Jin (3742471)

Subjects:

Frequency of tobacco smoking among smokers. by Prasanna Herath (20714794)

Subjects:

Correlation of lung function parameters with smoking variables. by Prasanna Herath (20714794)

Subjects:

Anthropometric characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

Subjects:

Respiratory clinical characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

Subjects:

Effect of the smoking factor on lung function parameters (FVC, FEV1, PEF, FEF 25_75). by Prasanna Herath (20714794)

Subjects:

Lung function parameters between smokers and non-smokers. by Prasanna Herath (20714794)

Subjects:

<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate.... by Atefeh Sadeghi (21253051)

“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”

Distribution of continuous variables of all 3 visits (visit 1 = day 0, visit 2 = day 35, and visit 3 = day 70) of the PCSO-524 group and the placebo group. Results are shown as mea... by Nattapon Riengvirodkij (11268720)

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; ^$(P < 0.05) significant vs. …”

RcbA and RcbB co-operatively decrease motility independent of CaCl₂ concentration. by Shobnom Mustaree (21728815)

Deep crypt secretory (DCS) cells are predominantly distributed in the proximal colon, with a progressive decrease towards the distal colon. by Daisuke Sugahara (2047696)